Mural Oncology plc (MURA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 54.6M |
| Enterprise Value | -52.84M |
| P/E Ratio | -0.29 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.64 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.17 |
Fiscal Year
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -1.81 |
| Return On Equity | -1.31 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -3.51M |
| EBITDA | -125M |
| Net Income | -128.51M |
| Diluted EPS | -7.58 |
Balance Sheet
| Total Cash | 58.87M |
| Total Cash/Share | 3.4 |
| Total Debt | 3.55M |
| Total Debt/Equity | 0.06 |
| Current Ratio | 5.9 |
| Book Value Per Share | 3.19 |
Price History
| 52-Week Change | -44.11 |
| 52-Week High | 4.74 |
| 52-Week Low | 0.95 |
| Moving Average 50 Days | 2.08 |
| Moving Average 200 Days | 2.37 |
Statistics
| Average Volume | 170,823 |
| Shares Outstanding | 17.34M |
| % Held by Institutions | 30.81 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
